查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1737603

微创椎间设备的全球市场:规模，占有率，趋势分析(2025年～2031年):MedCore(MIPLIF，MITLIF，其他)

MIS Interbody Devices Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: MIPLIF Market, MITLIF Market, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 97 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

侧入路腰椎椎间融合术 (LLIF) 是 2024 年市场上最大的细分领域。 MIPLIF 是成长最快的，预计所有细分领域的价值都将继续成长。另一方面，MIPLIF 由于价格大幅下降，市场占有率最小。

本报告涵盖了微创椎间融合术的细分领域，例如微创腰椎椎间融合术 (MIPLIF)、微创经腰椎椎间融合术 (MITLIF)、侧入路腰椎椎间融合术 (LLIF) 和斜入路侧入路椎间融合术 (OLIF)。

本报告包​​含来自七个不同地区 65 多个国家的数据。这些地区包括北美、拉丁美洲、西欧、中欧和东欧、中东、亚太地区和非洲。

市场报告资料型态

  • 销售量、平均售价、市场规模与成长趋势
  • 手术数量
  • 市场推动因素与阻碍因素
  • 2031 年市场预测，2024 年历史数据
  • 近期併购
  • 公司简介与产品组合
  • 主要竞争对手

全球微创椎间装置市场趋势

  • 该市场的主要推动因素是老年人口相对于年轻人口的增长，以及患者和外科医生越来越倾向于微创手术，因为此类手术恢復时间更短，对肌肉和组织的损伤更小。

全球市场占有率的洞察

Globus Medical/NuVasive

  • MIS椎间融合器市占率领先
  • 2023年初合併增强实力
  • 北美、西欧及世界其他地区市占率领先

美敦力

  • 市场第二大竞争对手。
  • 直接侧方椎间融合术 (DLIF®) 崭露头角
  • 所有地区市占率第二

DePuy Synthes

  • 全球第三大竞争对手
  • 未来成长取决于微创外科 (MIS) 市场的创新
  • 所有地区排名第三

范围摘要

目标地区

  • 北美(加拿大，美国)
  • 南美(阿根廷，玻利维亚，巴西，智利，哥伦比亚，哥斯大黎加，多明尼加共和国，厄瓜多，瓜地马拉，墨西哥，巴拿马，巴拉圭，秘鲁，波多黎各，乌拉圭，委内瑞拉)
  • 西欧(奥地利，荷比卢三国，法国，德国，义大利，葡萄牙，斯堪地那维亚，西班牙，瑞士，英国)
  • 中东欧(亚塞拜然，波罗的海国家，白俄罗斯，保加利亚，克罗埃西亚，捷克，乔治亚，希腊，匈牙利，哈萨克，波兰，罗马尼亚，俄罗斯，塞尔维亚，斯洛伐克，斯洛维尼亚，土耳其，乌克兰)
  • 中东(巴林，伊朗，以色列，科威特，阿曼，卡达，沙乌地阿拉伯，阿拉伯联合大公国)
  • 亚太地区(澳洲，柬埔寨，中国，香港，印度，印尼，日本，吉尔吉斯，澳门，马来西亚，蒙古，缅甸，纽西兰，巴基斯坦，菲律宾，新加坡，韩国，斯里兰卡，台湾，泰国，乌兹别克，越南)
  • 非洲(阿尔及利亚，埃及，衣索比亚，迦纳，肯亚，利比亚，摩洛哥，奈及利亚，南非，苏丹，乌干达)

基准年:2024年

预测期间:2025年～2031年

过去资料:2021年～2023年

定量资料

  • 市场规模
  • 市场占有率
  • 市场预测
  • 市场成长率
  • 销售台数
  • 平均销售价格

定性的资料

  • 市场成长趋势
  • 市场限制器
  • 竞争分析及龙头企业的SWOT
  • 合併和收购
  • 企业简介
  • 产品系列
  • FDA回收
  • 颠覆性技术
  • 疾病概要

资料来源

  • 对产业领导者的一次采访
  • 政府医生资料
  • 法规资料
  • 医院资料
  • 进出口资料
  • 公司内部资料库

本报告提供全球微创椎间设备市场相关调查，市场概要，以及市场分析与预测，促进因素与阻碍因素，竞争情形等资讯。

目录

微创椎间设备市场

  • 摘要整理
    • 全球MIS椎间设备市场概要
    • 竞争分析
    • 手术的市场区隔
    • 市场区隔
    • 对象地区
  • 简介
  • 手术数量
    • MIPLIF手术
    • MITLIF手术
    • LLIF手术
    • OLIF手术
  • 市场概要
    • 各市场区隔
    • 各地区
  • 市场分析与预测
    • MIS椎间设备市场全体
    • MIPLIF市场
    • MITLIF市场
    • LLIF市场
    • OLIF市场
  • 促进因素与阻碍因素
  • 竞争市场占有率分析
Product Code: iDATA_GLMIS25_MC_ID

The largest subsegment of this market in 2024 was the lateral lumbar interbody fusion (LLIF). It is expected that all subsegments keep growing in value with the MIPLIF being the fastest growing. On the other hand, MIPLIF has the smallest market value share because of a high decline in prices.

The full report suite on the global market for MIS interbody devices includes subsegments for the minimally invasive interbody devices such as minimally invasive posterior lumbar interbody fusion (MIPLIF), minimally invasive transforaminal lumbar interbody fusion (MITLIF), lateral lumbar interbody fusion (LLIF) and oblique lateral interbody (OLIF).

This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

MARKET REPORT DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031, and Historical Data to 2024
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitor

GLOBAL MIS INTERBODY DEVICE MARKET TRENDS

  • The major driver of this market is the increase in the elderly population relative to younger demographics and the tendency of the patients and surgeons for less invasive surgeries, as they result in less recovery time and less damage to the muscles and tissues.

Global Market Share Insights

1. 1. Globus Medical / NuVasive

  • Leading competitor in the total MIS interbody device market.
  • Strengthened by the merger in early 2023.
  • Held leading share in North America, Western Europe and Rest of the World.

2. 2. Medtronic

  • Second leading competitor in the market.
  • Presence supported by Direct Lateral Interbody Fusion (DLIF(R)).
  • Held second-largest share in all regions reported.

3. 3. DePuy Synthes

  • Third-leading competitor globally.
  • Future growth depends on innovation in the MIS market.
  • Held third position in all regions reported.

Research Scope Summary

Regions

  • North America (Canada, United States)
  • Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
  • Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
  • Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
  • Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
  • Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
  • Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2024

Forecast Period: 2025-2031

Historical Data: 2021-2023

Quantitative Data

  • Market Size
  • Market Shares
  • Market Forecasts
  • Market Growth Rates
  • Units Sold
  • Average Selling Prices

Qualitative Data

  • Market Growth Trends
  • Market Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles
  • Product Portfolios
  • FDA Recalls
  • Disruptive Technologies
  • Disease Overviews

Data Sources

  • Primary Interviews with Industry Leaders
  • Government Physician Data
  • Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

MIS Interbody Device Market

  • 4.1 Executive Summary
    • 4.1.1 Global MIS Interbody Device Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Procedure Segmentation
    • 4.1.4 Market Segmentation
    • 4.1.5 Regions Included
  • 4.2 Introduction
      • 4.2.1.1 Minimally Invasive Posterior Lumbar Interbody Fusion
      • 4.2.1.2 Minimally Invasive Transforaminal Lumbar Interbody Fusion
      • 4.2.1.3 Lateral Lumbar Interbody Fusion
      • 4.2.1.4 Direct Lateral Interbody Fusion
      • 4.2.1.5 eXtreme Lateral Interbody Fusion
      • 4.2.1.6 Guided Lateral Interbody Fusion
      • 4.2.1.7 Oblique Lateral Interbody Fusion
  • 4.3 Procedure Numbers
    • 4.3.1 MIPLIF Procedures
    • 4.3.2 MITLIF Procedures
    • 4.3.3 LLIF Procedures
    • 4.3.4 OLIF Procedures
  • 4.4 Market Overview
    • 4.4.1 By Segment
    • 4.4.2 By Region
  • 4.5 Market Analysis and Forecast
    • 4.5.1 Total MIS Interbody Device Market
    • 4.5.2 MIPLIF Market
    • 4.5.3 MITLIF Market
    • 4.5.4 LLIF Market
    • 4.5.5 OLIF Market
  • 4.6 Drivers and Limiters
    • 4.6.1 Market Drivers
    • 4.6.2 Market Limiters
  • 4.7 Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 4-1: MIS Interbody Device Market, Global, 2024 & 2031
  • Chart 4-2: MIS Interbody Device Procedures, Global, 2024
  • Chart 4-3: MIS Interbody Device Procedures by Segment, Global, 2021 - 2031
  • Chart 4-4: MIS Interbody Device Market by Segment, Global, 2021 - 2031
  • Chart 4-5: MIS Interbody Device Market by Region, Global, 2021 - 2031
  • Chart 4-6: Leading Competitors, MIS Interbody Fusion Market, Global, 2024

LIST OF FIGURES

  • Figure 4-1: MIS Interbody Device Procedure Segmentation
  • Figure 4-2: MIS Interbody Device Market Segmentation
  • Figure 4-3: MIS Interbody Device Regions Covered, Global (1 of 2)
  • Figure 4-4: MIS Interbody Device Regions Covered (2 of 2)
  • Figure 4-5: MIS Interbody Device Procedures by Segment, Global, 2021 - 2031
  • Figure 4-6: MIS Interbody Device Procedures by Region, Global, 2021 - 2031
  • Figure 4-7: MIS Interbody Device Procedures by Country, North America, 2021 - 2031
  • Figure 4-8: MIS Interbody Device Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-9: MIS Interbody Device Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-10: MIS Interbody Device Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-11: MIS Interbody Device Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-12: MIS Interbody Device Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-13: MIS Interbody Device Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-14: MIS Interbody Device Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-15: MIS Interbody Device Procedures by Country, Africa, 2021 - 2031
  • Figure 4-16: MIPLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-17: MIPLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-18: MIPLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-19: MIPLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-20: MIPLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-21: MIPLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-22: MIPLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-23: MIPLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-24: MIPLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-25: MIPLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-26: MITLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-27: MITLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-28: MITLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-29: MITLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-30: MITLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-31: MITLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-32: MITLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-33: MITLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-34: MITLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-35: MITLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-36: LLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-37: LLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-38: LLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-39: LLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-40: LLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-41: LLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-42: LLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-43: LLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-44: LLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-45: LLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-46: OLIF Procedures by Region, Global, 2021 - 2031
  • Figure 4-47: OLIF Procedures by Country, North America, 2021 - 2031
  • Figure 4-48: OLIF Procedures by Country, Latin America, 2021 - 2031
  • Figure 4-49: OLIF Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-50: OLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-51: OLIF Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-52: OLIF Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-53: OLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 2)
  • Figure 4-54: OLIF Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 2)
  • Figure 4-55: OLIF Procedures by Country, Africa, 2021 - 2031
  • Figure 4-56: MIS Interbody Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 4-57: MIS Interbody Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 4-58: MIS Interbody Device Market, Global, 2021 - 2031
  • Figure 4-59: Units Sold by Region, MIS Interbody Device Market, Global, 2021 - 2031
  • Figure 4-60: Average Selling Price by Region, MIS Interbody Device Market, Global, 2021 - 2031 (US$)
  • Figure 4-61: Market Value by Region, MIS Interbody Device Market, Global, 2021 - 2031 (US$M)
  • Figure 4-62: MIPLIF Market, Global, 2021 - 2031
  • Figure 4-63: Units Sold by Region, MIPLIF Market, Global, 2021 - 2031
  • Figure 4-64: Average Selling Price by Region, MIPLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-65: Market Value by Region, MIPLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-66: MITLIF Market, Global, 2021 - 2031
  • Figure 4-67: Units Sold by Region, MITLIF Market, Global, 2021 - 2031
  • Figure 4-68: Average Selling Price by Region, MITLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-69: Market Value by Region, MITLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-70: LLIF Market, Global, 2021 - 2031
  • Figure 4-71: Units Sold by Region, LLIF Market, Global, 2021 - 2031
  • Figure 4-72: Average Selling Price by Region, LLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-73: Market Value by Region, LLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-74: OLIF Market, Global, 2021 - 2031
  • Figure 4-75: Units Sold by Region, OLIF Market, Global, 2021 - 2031
  • Figure 4-76: Average Selling Price by Region, OLIF Market, Global, 2021 - 2031 (US$)
  • Figure 4-77: Market Value by Region, OLIF Market, Global, 2021 - 2031 (US$M)
  • Figure 4-78: Leading Competitors, MIS Interbody Fusion Market, Global, 2024